AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Hancock Jaffe LaboratoriesAvingerEncisionPlusTherapeuticsInc .Lianluo Smart
SymbolNASDAQ:HJLINASDAQ:AVGROTCMKTS:ECIANASDAQ:PSTVNASDAQ:LLIT
Price Information
Current Price$0.36$0.45$0.67$1.73$0.41
52 Week RangeBuyBuyN/AN/AN/A
Beat the Market™ Rank
Overall Score1.21.41.30.40.5
Analysis Score3.53.30.00.00.0
Community Score2.32.72.52.22.7
Dividend Score0.00.00.00.00.0
Ownership Score0.00.04.00.00.0
Earnings & Valuation Score0.01.30.00.00.0
Analyst Ratings
Consensus RecommendationBuyBuyN/AN/AN/A
Consensus Price Target$3.00$1.40N/AN/AN/A
% Upside from Price Target735.42% upside211.11% upsideN/AN/AN/A
Trade Information
Market Cap$6.10 million$11.90 million$7.76 million$6.99 million$7.32 million
Beta1.761.26-0.220.420.8
Average Volume327,7891,367,26311,203266,7962,371,860
Sales & Book Value
Annual Revenue$30,000.00$9.13 million$7.67 million$7 million$380,000.00
Price / Sales229.011.541.011.0219.26
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.06 per share$0.67 per share$0.20 per share$0.31 per share($0.07) per share
Price / Book5.990.673.355.58-5.91
Profitability
Net Income$-7,630,000.00$-19,450,000.00$-200,000.00$-10,890,000.00$-4,450,000.00
EPSN/A($3.18)N/AN/AN/A
Trailing P/E Ratio0.00N/AN/AN/A0.00
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-211.96%-2.58%-138.13%N/A
Return on Equity (ROE)-263.14%-270.15%-8.89%-1,037.22%N/A
Return on Assets (ROA)-139.10%-78.28%-4.54%-9.69%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.57%0.89%N/A7.34%N/A
Current Ratio0.76%1.11%2.55%1.18%0.52%
Quick Ratio0.76%0.85%1.28%1.17%0.18%
Ownership Information
Institutional Ownership Percentage0.49%7.34%N/A6.26%1.34%
Insider Ownership Percentage6.40%0.51%35.70%0.07%22.90%
Miscellaneous
EmployeesN/AN/A3637129
Shares Outstanding19.13 million31.34 million11.58 million4.11 million17.69 million
Next Earnings Date6/11/2020 (Estimated)7/29/2020 (Estimated)8/10/2020 (Estimated)8/20/2020 (Estimated)8/21/2020 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.